Safety Shot Inc (SHOT)
USD 0.48
(5.52%)
USD 0.48
(5.52%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -15.08 Million USD | 0.92% |
| 2022 | -15.22 Million USD | 45.83% |
| 2021 | -28.1 Million USD | -346.8% |
| 2020 | -6.28 Million USD | -579.57% |
| 2019 | -925.46 Thousand USD | -158.22% |
| 2018 | -358.4 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -8.27 Million USD | 47.21% |
| 2024 Q1 | -15.67 Million USD | -176.11% |
| 2023 Q1 | -1.3 Million USD | 84.66% |
| 2023 Q3 | -7.73 Million USD | -2051.97% |
| 2023 FY | -15.08 Million USD | 0.92% |
| 2023 Q4 | -5.67 Million USD | 26.64% |
| 2023 Q2 | -359.59 Thousand USD | 72.51% |
| 2022 FY | -15.22 Million USD | 45.83% |
| 2022 Q4 | -8.53 Million USD | -265.72% |
| 2022 Q3 | -2.33 Million USD | -61.89% |
| 2022 Q2 | -1.44 Million USD | 50.66% |
| 2022 Q1 | -2.91 Million USD | 82.77% |
| 2021 Q3 | -4.8 Million USD | -15.84% |
| 2021 Q4 | -16.94 Million USD | -252.4% |
| 2021 FY | -28.1 Million USD | -346.8% |
| 2021 Q1 | -2.19 Million USD | 53.94% |
| 2021 Q2 | -4.15 Million USD | -89.05% |
| 2020 Q4 | -4.76 Million USD | -684.92% |
| 2020 Q2 | -433.37 Thousand USD | 10.05% |
| 2020 Q1 | -481.79 Thousand USD | 26.44% |
| 2020 FY | -6.28 Million USD | -579.57% |
| 2020 Q3 | -607.28 Thousand USD | -40.13% |
| 2019 Q1 | -73.54 Thousand USD | 0.0% |
| 2019 Q4 | -654.99 Thousand USD | -412.13% |
| 2019 Q3 | -127.89 Thousand USD | -85.28% |
| 2019 FY | -925.46 Thousand USD | -158.22% |
| 2019 Q2 | -69.02 Thousand USD | 6.14% |
| 2018 FY | -358.4 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 131.322% |
| Embecta Corp. | 70.4 Million USD | 121.425% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 180.319% |
| Dynavax Technologies Corporation | -6.38 Million USD | -136.078% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 92.792% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 135.951% |
| PainReform Ltd. | -9.34 Million USD | -61.42% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -91.652% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -234.729% |
| SCYNEXIS, Inc. | 67.04 Million USD | 122.498% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -386.78% |
| Cosmos Health Inc. | -18.54 Million USD | 18.658% |
| Journey Medical Corporation | -3.85 Million USD | -291.462% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -234.729% |
| Alpha Teknova, Inc. | -36.78 Million USD | 58.991% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 89.201% |
| Bright Green Corporation | -13.12 Million USD | -14.895% |
| Procaps Group, S.A. | 42.54 Million USD | 135.456% |
| Theratechnologies Inc. | -23.95 Million USD | 37.041% |
| Harrow Health, Inc. | -24.41 Million USD | 38.212% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -211.955% |
| Biofrontera Inc. | -20.13 Million USD | 25.076% |
| DURECT Corporation | -27.62 Million USD | 45.399% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 1246.128% |
| Cronos Group Inc. | -73.96 Million USD | 79.607% |
| OptiNose, Inc. | -35.48 Million USD | 57.492% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 98.495% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 64.257% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 163.067% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 405.016% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 9644.235% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -140.202% |
| Radius Health, Inc. | -25.79 Million USD | 41.518% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -144.733% |
| ProPhase Labs, Inc. | -16.78 Million USD | 10.124% |
| Phibro Animal Health Corporation | 2.41 Million USD | 724.298% |
| Procaps Group S.A. | 42.54 Million USD | 135.456% |
| Alvotech | -551.73 Million USD | 97.266% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -46.751% |
| Viatris Inc. | 54.7 Million USD | 127.574% |
| Rockwell Medical, Inc. | -8.43 Million USD | -78.73% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 4.803% |
| SIGA Technologies, Inc. | 68.06 Million USD | 122.159% |
| Tilray Brands, Inc. | -244.98 Million USD | 93.843% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 225.556% |
| Shineco, Inc. | -22.44 Million USD | 32.812% |
| PetIQ, Inc. | 2.13 Million USD | 807.792% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -250.619% |
| Incannex Healthcare Limited | -18.45 Million USD | 18.289% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 106.04% |
| Alimera Sciences, Inc. | -20.13 Million USD | 25.079% |
| Silver Spike Investment Corp. | 7.34 Million USD | 305.488% |
| Assertio Holdings, Inc. | -331.94 Million USD | 95.456% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -128.783% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -84.769% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 15.732% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 24.8% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 90.589% |
| Hempacco Co., Inc. | -13.12 Million USD | -14.909% |
| Talphera, Inc. | -18.39 Million USD | 18.014% |
| Alvotech | -551.73 Million USD | 97.266% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 142.318% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 104.617% |
| Currenc Group, Inc. | -15.3 Million USD | 1.46% |
| Kamada Ltd. | 8.28 Million USD | 282.074% |
| Indivior PLC | 2 Million USD | 854.152% |
| Evoke Pharma, Inc. | -7.79 Million USD | -93.564% |
| Flora Growth Corp. | -57.03 Million USD | 73.555% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 24.8% |
| Evolus, Inc. | -61.68 Million USD | 75.548% |
| HUTCHMED (China) Limited | 100.78 Million USD | 114.966% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 110.966% |
| Akanda Corp. | -32.27 Million USD | 53.267% |